P
2019
The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.
Report Code : A04930 | Pages : 255 | Category : Life Sciences
P
2023
The global in vitro diagnostics market was valued at $92.5 billion in 2022, and is projected to reach $138.4 billion by 2032, growing at a CAGR of 4.1% from 2023 to 2032.
Report Code : A00245 | Pages : 391 | Category : Life Sciences
P
2022
The global blood gas and electrolyte analyzers market size was valued at was valued at $1,698.7 Million in 2020, and is estimated to reach $2,625.23 Million by 2030, ...
Report Code : A04255 | Pages : 150 | Category : Life Sciences
P
2021
The global fetal bovine serum market size was valued at $796.25 million in 2020, and is projected to reach $1,375.53 million by 2030, registering a CAGR of 5.4% ...
Report Code : A04898 | Pages : 189 | Category : Life Sciences
P
2022
The global molecular diagnostics market was valued at $9.2 billion in 2020, and is projected to reach $23.9 billion by 2030, growing at a CAGR of 9.86% from 2021 to 2030.
Report Code : A01840 | Pages : 256 | Category : Life Sciences
P
2022
The global organ-on-chip market was valued at $103.44 million in 2020, and is projected to reach $1.6 billion by 2030, growing at a CAGR of 31.1% from 2021 to 2030.
Report Code : A02223 | Pages : 200 | Category : Life Sciences
P
2022
The global womens health diagnostics market was valued at $19.2 billion in 2020, and is projected to reach $36.3 billion by 2030, growing at a CAGR of 6.9% from 2021 to 2030.
Report Code : A04170 | Pages : 210 | Category : Life Sciences
P
2019
The global companion diagnostics market generated $1,678 million in 2018, and is projected to reach $6,452 million by 2026, growing at a CAGR of 18.3% from 2019 to 2026.
Report Code : A03393 | Pages : 199 | Category : Life Sciences
P
2022
The global global sepsis diagnostic market was valued at $569.49 million in 2020, and is projected to reach $1.2 billion by 2030, growing at a CAGR of 7.8% from 2021 to 2030.
Report Code : A03908 | Pages : 205 | Category : Life Sciences
P
2019
The global acute lymphocytic/lymphoblastic leukemia therapeutics market accounted for $2,334.5 million in 2018, and is expected to reach $3,528.8 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.
Report Code : A00460 | Pages : 113 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.